| Recruiting | GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL Non-hodgkin Lymphoma, Refractory Lymphoma, Chimeric Antigen Receptor T-cell | Phase 1 | 2026-04-30 |
| Not Yet Recruiting | Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody Advanced Solid Tumors | N/A | 2026-04-01 |
| Not Yet Recruiting | Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer Colorectal Cancer Metastatic, Fecal Microbiota Transplantation | EARLY_Phase 1 | 2026-03-31 |
| Recruiting | Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cance NSCLC (Advanced Non-small Cell Lung Cancer), EGFR, Myelosuppression | Phase 2 | 2025-12-08 |
| Recruiting | DLL3-Targeted PET/CT in Neuroendocrine Carcinoma DLL3-expressing Tumors, PET / CT, Neuroendocrine Cancer | N/A | 2025-12-01 |
| Not Yet Recruiting | Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar Nasopharyngeal Carcinoma (NPC), PET / CT | — | 2025-09-30 |
| Not Yet Recruiting | Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy Locally Advanced Breast Cancer (LABC) | Phase 1 / Phase 2 | 2025-09-23 |
| Not Yet Recruiting | The Effect of Semaglutide on Bone Health Osteoporosis, Osteoporosis Fracture, T2DM | Phase 4 | 2025-09-15 |
| Not Yet Recruiting | the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction Aft Postoperative Gastrointestinal Dysfunction (POGD) | N/A | 2025-09-01 |
| Recruiting | 68Ga-XACP3 PET/CT in Prostate Cancer Prostate Cancer, PET/CT, ACP3 | N/A | 2025-09-01 |
| Not Yet Recruiting | Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Locally Advanced Hypopharyngeal Cancer | Phase 2 | 2025-08-20 |
| Recruiting | Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC Locally Advanced Nasopharyngeal Carcinoma, Immunotherapy, Induction Therapy | Phase 2 | 2025-07-30 |
| Not Yet Recruiting | Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma Esophagus Cancer | Phase 2 | 2025-07-30 |
| Enrolling By Invitation | Ultrasound Assessment of Fetal Growth Parameters Fetal Clavicle Length, Fetal Scapular Width, Fetal Sternal Length | — | 2025-07-01 |
| Not Yet Recruiting | A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therap Non-Small Cell Lung Cancer, Adebrelimab, Apatinib | Phase 2 | 2025-06-30 |
| Active Not Recruiting | Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation Hepatic Neoplasm, Hepatic Cancer | Phase 1 / Phase 2 | 2025-06-29 |
| Active Not Recruiting | Study on the Effective Dose and Safety of Esketamine in Hysteroscopic Surgery Under Monitored Anesthesia Care Intrauterine Polyp, Intrauterine Synechiae | Phase 1 / Phase 2 | 2025-06-26 |
| Recruiting | T-cell Developmental Status in Patients With Malignant Hematological Tumors Hematologic Malignancy | — | 2025-06-22 |
| Recruiting | Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastat Non-Small Cell Lung Cancer, Myelosuppression | Phase 2 | 2025-05-09 |
| Recruiting | Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients Tumor, Carbonic Anhydrase IX | — | 2025-05-09 |
| Recruiting | PET/CT for Trop2 ADC Response Evaluation NSCLC NSCLC, Trop2, PET/CT | — | 2025-05-01 |
| Recruiting | Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML Acute Myeloid Leukemia, Relapse, Refractory AML | Phase 1 | 2025-03-15 |
| Recruiting | Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC Nasopharyngeal Neoplasms, PD-1 Inhibitor, Induction Therapy | Phase 2 | 2025-02-25 |
| Recruiting | Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma Lymphoma, Follicular Lymphoma, Refractory Lymphoma | Phase 2 | 2025-02-08 |
| Recruiting | Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients Acute Myeloid Leukemia | Phase 1 | 2024-12-12 |
| Recruiting | 68Ga-MY6349 PET/CT in Solid Tumors Solid Tumor, Trop2, PET/CT | — | 2024-12-10 |
| Not Yet Recruiting | Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer Ovarian Cancer | Phase 3 | 2024-12-01 |
| Enrolling By Invitation | IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms, Elderly, Chemotherapy | Phase 2 | 2024-11-13 |
| Recruiting | A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment Postoperative Complications, Postoperative Pain, Acupuncture | — | 2024-11-13 |
| Recruiting | SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carci Nasopharyngeal Cancinoma (NPC), SBRT, Immunotherapy | Phase 2 | 2024-11-05 |
| Recruiting | PET/CT for Trop2 ADC Response Evaluation Cancers Breast Cancer, Trop2, PET/CT | — | 2024-11-01 |
| Recruiting | Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL Diffuse Large B-cell Lymphoma, Relapsed and Refractory | Phase 2 | 2024-10-21 |
| Recruiting | A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer Positron-Emission Tomography(PET), Prostate Cancer, Trophoblast Cell Surface Antigen 2 | N/A | 2024-10-01 |
| Recruiting | Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple My Multiple Myeloma, Relapsed/Refractory | Phase 2 | 2024-09-24 |
| Recruiting | Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hema Hematological Malignancy, Lymphocytopenia | Phase 2 | 2024-09-01 |
| Recruiting | Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymph Marginal Zone Lymphoma | N/A | 2024-06-23 |
| Recruiting | Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression Refractory Solid Tumor | Phase 1 | 2024-06-12 |
| Recruiting | A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcino Gastric/Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2024-05-19 |
| Not Yet Recruiting | Dexmedetomidine Premedication for Post-anaesthesia Sleep Disturbance Postoperative Sleep Disturbance | Phase 3 | 2024-05-01 |
| Recruiting | To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Prostate Cancer | Phase 2 | 2024-05-01 |
| Unknown | Efficacy and Safety Evaluation of Prebiotics Combined With Quadruple Probiotics in Improving Functional Consti Functional Constipation | N/A | 2024-05-01 |
| Completed | Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate C Metastatic Castration-resistant Prostate Cancer, mCRPC | Phase 1 | 2024-04-05 |
| Recruiting | Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) Locally Advanced Prostate Cancer, Oligometastatic Prostate Cancer | Phase 2 | 2024-04-01 |
| Recruiting | Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma Follicular Lymphoma, Newly Diagnosed | Phase 2 | 2024-03-31 |
| Completed | 68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Nasopharyngeal Cancer | — | 2024-01-31 |
| Recruiting | Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery Pituitary Neoplasms | N/A | 2024-01-22 |
| Terminated | ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer Tumor, Solid Tumor, Thyroid Cancer | N/A | 2024-01-04 |
| Recruiting | Effect of Oliceridine on Rebound Pain Rebound Pain, Arthroscopic Knee Surgery, Oliceridine | — | 2024-01-01 |
| Recruiting | 68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers Tumor, PD-L1 | — | 2023-12-31 |
| Recruiting | All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple My Multiple Myeloma in Relapse, Multiple Myeloma, Refractory | Phase 2 | 2023-11-22 |
| Recruiting | Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma | Phase 2 | 2023-11-22 |
| Recruiting | Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma, Refractory T-Cell Lymphoma | Phase 2 | 2023-11-22 |
| Recruiting | AZA Combined With RCHOP in P53-mutated DLBCL. DLBCL - Diffuse Large B Cell Lymphoma, TP53 | Phase 2 | 2023-11-22 |
| Recruiting | Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma Follicular Lymphoma, Refractory B-Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma | Phase 2 | 2023-11-22 |
| Recruiting | 68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis. Primary Myelofibrosis | — | 2023-11-22 |
| Recruiting | Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Adebrelimab, Hepatocellular Carcinoma, Transformation | Phase 2 | 2023-11-15 |
| Recruiting | Graves' Disease Remission Study: MycoMeth Combo Graves' Disease | Phase 2 / Phase 3 | 2023-10-16 |
| Completed | ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors Tumor, Solid Tumor, Positron-Emission Tomography | N/A | 2023-10-01 |
| Recruiting | Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertens AF - Atrial Fibrillation, HTN-Hypertension | N/A | 2023-09-01 |
| Unknown | Characterizing Myositis With 68Ga-FAPI PET/CT Myositis, Idiopathic Inflammatory Myopathies | EARLY_Phase 1 | 2023-07-01 |
| Unknown | Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT Spondyloarthritis, Axial Spondyloarthritis, Ankylosing Spondylitis | N/A | 2023-07-01 |
| Recruiting | 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG SSTR2, FAP, Positron-Emission Tomography | N/A | 2023-04-09 |
| Unknown | Mobile Internet Healthcare and Three Disciplines Co-management Intervention for Overweight/Obese Prediabetic P Overweight/Obesity, Prediabetes, Weight Management | N/A | 2023-03-28 |
| Unknown | Individualized Precision Treatment Based on Ovarian Cancer Organoid Model Ovarian Cancer | N/A | 2022-12-01 |
| Recruiting | VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia, Myeloid, Acute, AML Stage, Adult | Phase 2 | 2022-12-01 |
| Completed | 68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers PET/CT, hLAG-3, TUMOR | — | 2022-10-10 |
| Completed | APA on Sleep Quality in Women With PCOS Polycystic Ovary Syndrome | N/A | 2022-07-24 |
| Completed | 68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer Tumor, Solid, Positron-Emission Tomography | N/A | 2022-07-01 |
| Recruiting | Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elder Acute Myeloid Leukemia | Phase 2 | 2022-07-01 |
| Completed | Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma | Phase 1 | 2022-06-15 |
| Completed | Evaluation of 177Lu-TATE-EB-01（LNC1010）in SSTR2-positive Tumors SSTR2-positive Tumors | Phase 1 / Phase 2 | 2022-06-01 |
| Completed | Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compar Gastric Cancer, Pancreatic Cancer, Liver Cancer | N/A | 2022-06-01 |
| Unknown | A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer Ovarian Cancer | — | 2022-04-01 |
| Unknown | Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC Colorectal Neoplasms | Phase 2 | 2022-03-25 |
| Unknown | Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients Rheumatoid Arthritis | — | 2022-03-04 |
| Completed | Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer Tumor, Solid, Positron-Emission Tomography | N/A | 2022-03-01 |
| Completed | Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors Refractory Solid Tumor | Phase 2 | 2022-02-22 |
| Unknown | A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Pa Advanced Non-Small Cell Lung Cancer | Phase 2 | 2022-01-21 |
| Recruiting | Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia | Phase 2 | 2022-01-12 |
| Completed | Comparative Diagnostic Yield of Contrast-Enhanced Versus Conventional Ultrasound Guidance for Coaxial Biopsy o Hepatic Lesions | — | 2022-01-01 |
| Completed | the Relationship Between FAPI Results and Myocardial Fibrosis After Acute Myocardial Infarction Acute Myocardial Infarction (AMI) | — | 2021-12-03 |
| Unknown | Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC Non-small Cell Lung Cancer Stage IV | Phase 2 | 2021-08-30 |
| Unknown | Prevention In Community Clinics From Diabetic Kidney Disease Diabetic Nephropathies | N/A | 2021-08-01 |
| Completed | Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer Tumor, Solid, FAPI, PET/CT, Metastasis | N/A | 2021-06-18 |
| Unknown | Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary L Multiple Primary Lung Cancer | Phase 1 / Phase 2 | 2021-06-01 |
| Unknown | 68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced 177Lu-DOTA-FAPI, 68Ga-DOTA-FAPI, Theranostic | Phase 1 | 2021-04-13 |
| Unknown | Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients Lung Neoplasms | Phase 2 | 2020-07-01 |
| Completed | 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma Lung Adenocarcinoma, 18F-FDG, 68Ga-FAPI | N/A | 2020-07-01 |
| Unknown | Diabetic Complications and Obstructive Sleep Apnea Diabetic Complications and Obstructive Sleep Apnea | — | 2020-06-10 |
| Active Not Recruiting | Time Restricted Eating on Impaired Glucose Regulation(TRIG Trial) Impaired Glucose Regulation, Overweight/Obese, Time-restricted Eating | N/A | 2020-05-04 |
| Unknown | Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer Locally Advanced Colon Cancer | Phase 2 | 2020-03-04 |
| Recruiting | Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children Nephrotic Syndrome, Rituximab, Children | — | 2020-03-01 |
| Completed | Difference Between Mean Gestational Sac Diameter and Crown-rump Length as a Marker of First-trimester Pregnanc Recurrent Spontaneous Abortion | — | 2020-01-01 |
| Unknown | Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanc Locally Advanced or Metastatic Gastric Adenocarcinoma | Phase 1 / Phase 2 | 2020-01-01 |
| Recruiting | Comparison of FDG and FAPI in Patients With Various Types of Cancer Tumor, Solid, Positron-Emission Tomography, Metastasis | N/A | 2019-10-20 |
| Unknown | Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer NSCLC, PET/CT, Biopsy | N/A | 2019-10-01 |
| Recruiting | A Nurse Cohort Study in Xiamen, China Hypertension | — | 2019-03-20 |
| Recruiting | Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) Type 2 Diabetes Patients, Overweight and Obesity, Hyperglycaemia (Diabetic) | Phase 4 | 2019-01-10 |
| Completed | Time-Restricted Feeding(TRF) on Overweight/Obese Women with Polycystic Ovarian Syndrome (PCOS) Polycystic Ovary Syndrome (PCOS), Overweight and Obesity | N/A | 2019-01-07 |
| Completed | Association Between Peri-procedural Myocardial Injury and Quantitative Blood Flow Ratio Coronary Arterial Disease (CAD) | — | 2019-01-01 |
| Unknown | Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 D T2DM | Phase 4 | 2018-06-10 |
| Unknown | Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety | — | 2018-05-01 |
| Recruiting | Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission Axial Spondyloarthritis | N/A | 2018-02-15 |
| Unknown | SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy Lung Cancer Metastatic | Phase 2 | 2016-11-01 |
| Unknown | Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticodu Pancreatic Cancer, Bile Duct Cancer, Duodenal Cancer | N/A | 2016-09-01 |
| Unknown | Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma Hepatocellular Carcinoma, Recurrence | N/A | 2013-07-01 |
| Completed | Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patient Diabetes Mellitus, Type 2 | Phase 4 | 2012-08-01 |